Literature DB >> 20615998

A metagenomic β-glucuronidase uncovers a core adaptive function of the human intestinal microbiome.

Karine Gloux1, Olivier Berteau, Hanane El Oumami, Fabienne Béguet, Marion Leclerc, Joël Doré.   

Abstract

In the human gastrointestinal tract, bacterial β-D-glucuronidases (BG; E.C. 3.2.1.31) are involved both in xenobiotic metabolism and in some of the beneficial effects of dietary compounds. Despite their biological significance, investigations are hampered by the fact that only a few BGs have so far been studied. A functional metagenomic approach was therefore performed on intestinal metagenomic libraries using chromogenic glucuronides as probes. Using this strategy, 19 positive metagenomic clones were identified but only one exhibited strong β-D-glucuronidase activity when subcloned into an expression vector. The cloned gene encoded a β-D-glucuronidase (called H11G11-BG) that had distant amino acid sequence homologies and an additional C terminus domain compared with known β-D-glucuronidases. Fifteen homologs were identified in public bacterial genome databases (38-57% identity with H11G11-BG) in the Firmicutes phylum. The genomes identified derived from strains from Ruminococcaceae, Lachnospiraceae, and Clostridiaceae. The genetic context diversity, with closely related symporters and gene duplication, argued for functional diversity and contribution to adaptive mechanisms. In contrast to the previously known β-D-glucuronidases, this previously undescribed type was present in the published microbiome of each healthy adult/child investigated (n = 11) and was specific to the human gut ecosystem. In conclusion, our functional metagenomic approach revealed a class of BGs that may be part of a functional core specifically evolved to adapt to the human gut environment with major health implications. We propose consensus motifs for this unique Firmicutes β-D-glucuronidase subfamily and for the glycosyl hydrolase family 2.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20615998      PMCID: PMC3063586          DOI: 10.1073/pnas.1000066107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Intestinal microbiota: a potential diet-responsive prevention target in ApcMin mice.

Authors:  Volker Mai; Lisa H Colbert; Susan N Perkins; Arthur Schatzkin; Stephen D Hursting
Journal:  Mol Carcinog       Date:  2007-01       Impact factor: 4.784

2.  Genetic characterization of the beta-glucuronidase enzyme from a human intestinal bacterium, Ruminococcus gnavus.

Authors:  Diane Beaud; Patrick Tailliez; Jamila Anba-Mondoloni
Journal:  Microbiology (Reading)       Date:  2005-07       Impact factor: 2.777

3.  Origin of intestinal beta-glucuronidase in germfree, monocontaminated and conventional rats.

Authors:  T O Rod; T Midtvedt
Journal:  Acta Pathol Microbiol Scand B       Date:  1977-08

4.  Towards the human intestinal microbiota phylogenetic core.

Authors:  Julien Tap; Stanislas Mondot; Florence Levenez; Eric Pelletier; Christophe Caron; Jean-Pierre Furet; Edgardo Ugarte; Rafael Muñoz-Tamayo; Denis L E Paslier; Renaud Nalin; Joel Dore; Marion Leclerc
Journal:  Environ Microbiol       Date:  2009-07-06       Impact factor: 5.491

5.  Intestinal bacterial metabolism of flavonoids and its relation to some biological activities.

Authors:  D H Kim; E A Jung; I S Sohng; J A Han; T H Kim; M J Han
Journal:  Arch Pharm Res       Date:  1998-02       Impact factor: 4.946

6.  Distribution of beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene gus in human colonic bacteria.

Authors:  Marta Dabek; Sheila I McCrae; Valerie J Stevens; Sylvia H Duncan; Petra Louis
Journal:  FEMS Microbiol Ecol       Date:  2008-06-04       Impact factor: 4.194

7.  Proposal to unify Clostridium orbiscindens Winter et al. 1991 and Eubacterium plautii (Séguin 1928) Hofstad and Aasjord 1982, with description of Flavonifractor plautii gen. nov., comb. nov., and reassignment of Bacteroides capillosus to Pseudoflavonifractor capillosus gen. nov., comb. nov.

Authors:  Jean-Philippe Carlier; Marie Bedora-Faure; Guylène K'ouas; Corentine Alauzet; Francine Mory
Journal:  Int J Syst Evol Microbiol       Date:  2009-08-04       Impact factor: 2.747

8.  Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease.

Authors:  Ben Willing; Jonas Halfvarson; Johan Dicksved; Magnus Rosenquist; Gunnar Järnerot; Lars Engstrand; Curt Tysk; Janet K Jansson
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

9.  Development of the human infant intestinal microbiota.

Authors:  Chana Palmer; Elisabeth M Bik; Daniel B DiGiulio; David A Relman; Patrick O Brown
Journal:  PLoS Biol       Date:  2007-06-26       Impact factor: 8.029

10.  Bioprospecting metagenomes: glycosyl hydrolases for converting biomass.

Authors:  Luen-Luen Li; Sean R McCorkle; Sebastien Monchy; Safiyh Taghavi; Daniel van der Lelie
Journal:  Biotechnol Biofuels       Date:  2009-05-18       Impact factor: 6.040

View more
  64 in total

1.  Shifting from a gene-centric to metabolite-centric strategy to determine the core gut microbiome.

Authors:  Julian R Marchesi
Journal:  Bioeng Bugs       Date:  2011-11-01

Review 2.  Metagenomic analyses: past and future trends.

Authors:  Carola Simon; Rolf Daniel
Journal:  Appl Environ Microbiol       Date:  2010-12-17       Impact factor: 4.792

3.  Feasibility of Genome-Wide Screening for Biosafety Assessment of Probiotics: A Case Study of Lactobacillus helveticus MTCC 5463.

Authors:  S Senan; J B Prajapati; C G Joshi
Journal:  Probiotics Antimicrob Proteins       Date:  2015-12       Impact factor: 4.609

4.  Functional metagenomics reveals novel salt tolerance loci from the human gut microbiome.

Authors:  Eamonn P Culligan; Roy D Sleator; Julian R Marchesi; Colin Hill
Journal:  ISME J       Date:  2012-04-26       Impact factor: 10.302

Review 5.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

Review 6.  Microbiome and malignancy.

Authors:  Claudia S Plottel; Martin J Blaser
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

Review 7.  The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.

Authors:  Maryann Kwa; Claudia S Plottel; Martin J Blaser; Sylvia Adams
Journal:  J Natl Cancer Inst       Date:  2016-04-22       Impact factor: 13.506

Review 8.  Drug-gut microbiota interactions: implications for neuropharmacology.

Authors:  Jacinta Walsh; Brendan T Griffin; Gerard Clarke; Niall P Hyland
Journal:  Br J Pharmacol       Date:  2018-06-28       Impact factor: 8.739

9.  Active site flexibility revealed in crystal structures of Parabacteroides merdae β-glucuronidase from the human gut microbiome.

Authors:  Michael S Little; Samantha M Ervin; William G Walton; Ashutosh Tripathy; Yongmei Xu; Jian Liu; Matthew R Redinbo
Journal:  Protein Sci       Date:  2018-10-27       Impact factor: 6.725

Review 10.  The role of the gut microbiota in nutrition and health.

Authors:  Harry J Flint; Karen P Scott; Petra Louis; Sylvia H Duncan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-09-04       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.